Sun Pharmaceutical Industries Share Price Today - Live Blog for May 13, 2025

Sun Pharmaceutical Industries Ltd witnessed a notable 0.10% surge in its share price and is presently trading at ₹1,703.00, captivating the attention of market participants.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.08% upswing and is currently trading at ₹1,702.65, indicating strong market sentiment.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.01% decline, and it currently trades at ₹1,698.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,697.75. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,697.75. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd experienced a -0.12% dip in its share price and is currently trading at ₹1,695.95. The stock has a PE ratio of 35.3900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,699.55, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.04%, reaching a current market price of ₹1,699.90. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.09%, reaching the current market price of ₹1,696.10. This development underscores the stock's growing popularity.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.09% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,696.10 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

With a -0.20% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,693.70. This development raises questions about the factors behind the decline. The stock's PE ratio is 35.3900, while the industry PE is 33.5236.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.01% increase and currently trading at ₹1,697.10 per share. This upward trajectory is turning heads in the market.

After a -0.18% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,697.00. The stock has a PE ratio of 35.3900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd showed no price shifts, holding steady at ₹1,700.00. While the stock's performance remains consistent, it's worth noting that its PE ratio is 35.3900, while the industry PE is 33.5236.

Sun Pharmaceutical Industries Ltd share price has declined by -0.01%, and it's currently trading at ₹1,703.20. The stock maintains a PE of 35.3900, while the industry PE is 33.5236, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,703.20. The stock has a PE ratio of 35.3900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.29%, reaching the current market price of ₹1,701.15. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.14% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,697.35, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd shares saw a -0.19% decrease, reaching a current market price of ₹1,695.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 35.3900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Following a noteworthy 0.08% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,696.00. When it comes to valuation, this stock has a PE ratio of 35.3900, with the industry PE ratio at 33.5236.

Sun Pharmaceutical Industries Ltd experienced a -0.57% downturn in its share price, and it's currently trading at ₹1,693.25. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.17%, reaching a current market price of ₹1,704.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.13% drop, and it's now trading at ₹1,705.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.79%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,708.20, and market participants are assessing the implications. The stock has a PE ratio of 35.3900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.35%, a situation worth noting. At present, the stock is trading at ₹1,723.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 35.3900, while the industry PE ratio is 33.5236.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.40%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,725.95 per share.